Literature DB >> 2245860

Neodymium: YAG laser hysteroscopy in large submucous fibroids.

J Donnez1, S Gillerot, D Bourgonjon, F Clerckx, M Nisolle.   

Abstract

The preoperative use of a potent, subcutaneously injected gonadotropin-releasing hormone agonist (GnRH-a) was evaluated in a series of 60 women with large submucosal fibroids. Myomectomy by hysteroscopy and Nd:YAG laser was easily performed. In 12 cases, the largest portion of the myoma was not inside the uterine cavity and myomectomy was carried by a two-step hysteroscopy. In women who wished to become pregnant, a pregnancy rate of 66% was achieved. Advantages of preoperative use of a GnRH-a are (1) the significant decrease of the fibroid size, (2) a lower fluid absorption, and (3) the restoration of a normal hemoglobin concentration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2245860     DOI: 10.1016/s0015-0282(16)53994-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

Review 1.  GnRH agonists: do they have a place in the modern management of fibroid disease?

Authors:  Vikram Sinai Talaulikar; Anna-Maria Belli; Isaac Manyonda
Journal:  J Obstet Gynaecol India       Date:  2012-09-27

2.  Fertility Enhancing Hysteroscopic Surgery: Our Experience.

Authors:  B S Duggal; R K Sharma; P Tarneja; S K Rath; R D Wadhwa
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  [Hysteroscopic surgery].

Authors:  R Kimmig
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

4.  [Formulating indications for treatment of benign tumors of the uterus].

Authors:  R A Steiner; U Haller
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

Review 5.  Lasers in endoscopic surgery.

Authors:  T Gyr; S Spörri; M Frenz; H J Altermatt; A W Brandenberger; E Dreher
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

Review 6.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

Review 7.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

8.  Radiofrequency ablation for treatment of symptomatic uterine fibroids.

Authors:  Siân Jones; Peter O'Donovan; David Toub
Journal:  Obstet Gynecol Int       Date:  2011-09-27

9.  Thermal ablation of uterine fibroids using MR-guided focused ultrasound-a truly non-invasive treatment modality.

Authors:  Alexander Chapman; Gail ter Haar
Journal:  Eur Radiol       Date:  2007-05-01       Impact factor: 7.034

10.  Hysteroscopic myomectomy: our experience and review.

Authors:  J L Muñoz; J S Jiménez; C Hernández; G Vaquero; C Pérez Sagaseta; R Noguero; P Miranda; J M Hernández; P De la Fuente
Journal:  JSLS       Date:  2003 Jan-Mar       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.